Institutional investors purchased a net $2.3 million shares of VICL during the quarter ended March 2013. This may signal that the smart money is gaining interest in this company as the 46.87% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
PYRAMIS GLOBAL ADVISORS LLC Bought 2.9 Million shares of Vical Inc
FEDERATED EQUITY MANAGEMENT CO. ... Bought 2.3 Million shares of Vical Inc
ARIEL INVESTMENTS LLC Bought 1.1 Million shares of Vical Inc